Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice

BACKGROUND: Economic implications of chemotherapy-induced febrile neutropenia (FN) in European and Australian clinical practice are largely unknown. METHODS: Data were obtained from a European (97%) and Australian (3%) observational study of patients with non-Hodgkin’s lymphoma (NHL) receiving CHOP...

Descripción completa

Detalles Bibliográficos
Autores principales: Weycker, Derek, Danel, Aurelie, Marciniak, Anne, Bendall, Kate, Lipsitz, Michael, Pettengell, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488560/
https://www.ncbi.nlm.nih.gov/pubmed/22913768
http://dx.doi.org/10.1186/1471-2407-12-362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488560/
https://www.ncbi.nlm.nih.gov/pubmed/22913768
http://dx.doi.org/10.1186/1471-2407-12-362

Ejemplares similares